The impact of BCR‐ABL1 transcript type on tyrosine kinase inhibitor responses and outcomes in patients with chronic myeloid leukemia

Cancer, EarlyView.


from Cancer via ola Kala on Inoreader https://ift.tt/2FhxzWX
via IFTTT